{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:09:43Z","timestamp":1787864983582,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.ijcard.2023.131611","type":"journal-article","created":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T11:33:35Z","timestamp":1701084815000},"page":"131611","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Irreversible myocardial injury attenuates the benefits of sacubitril\/valsartan in heart failure patients"],"prefix":"10.1016","volume":"397","author":[{"given":"Hong-Mi","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"In-Chang","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye Jung","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeonyee E.","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun-Jung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Bean","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Pyo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyung-Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goo-Yeong","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.ijcard.2023.131611_bb0005","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijcard.2023.131611_bb0010","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3904\/kjim.2020.105","article-title":"Angiotensin receptor-neprilysin inhibitor for the treatment of heart failure: a review of recent evidence","volume":"35","author":"Choi","year":"2020","journal-title":"Korean J. Intern. Med."},{"issue":"11","key":"10.1016\/j.ijcard.2023.131611_bb0015","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1001\/jama.2019.12821","article-title":"Association of Change in N-terminal pro-B-type natriuretic peptide following initiation of Sacubitril-valsartan treatment with cardiac structure and function in patients with heart failure with reduced ejection fraction","volume":"322","author":"Januzzi","year":"2019","journal-title":"JAMA."},{"issue":"3","key":"10.1016\/j.ijcard.2023.131611_bb0020","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1002\/ehf2.13285","article-title":"Reverse remodelling by sacubitril\/valsartan predicts the prognosis in heart failure with reduced ejection fraction","volume":"8","author":"Moon","year":"2021","journal-title":"ESC Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2023.131611_bb0025","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.jchf.2019.02.015","article-title":"Outcomes and effect of treatment according to etiology in HFrEF: an analysis of PARADIGM-HF","volume":"7","author":"Balmforth","year":"2019","journal-title":"JACC Heart Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2023.131611_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1161\/CIRCULATIONAHA.121.054892","article-title":"Effect of Neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction","volume":"144","author":"Docherty","year":"2021","journal-title":"Circulation."},{"issue":"20","key":"10.1016\/j.ijcard.2023.131611_bb0035","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1056\/NEJMoa2104508","article-title":"Angiotensin receptor-Neprilysin inhibition in acute myocardial infarction","volume":"385","author":"Pfeffer","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2023.131611_bb0040","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1016\/j.jcmg.2022.03.019","article-title":"Reverse remodeling assessed by left atrial and ventricular strain reflects treatment response to Sacubitril\/valsartan","volume":"15","author":"Moon","year":"2022","journal-title":"JACC Cardiovasc. Imaging"},{"issue":"1","key":"10.1016\/j.ijcard.2023.131611_bb0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2014.10.003","article-title":"Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"28","author":"Lang","year":"2015","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"11","key":"10.1016\/j.ijcard.2023.131611_bb0050","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1161\/01.CIR.0000120294.67948.E3","article-title":"Role of cardiac magnetic resonance imaging in the assessment of myocardial viability","volume":"109","author":"Shan","year":"2004","journal-title":"Circulation."},{"issue":"1","key":"10.1016\/j.ijcard.2023.131611_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.echo.2019.07.001","article-title":"Guidelines for performance, interpretation, and application of stress echocardiography in ischemic heart disease: from the American Society of Echocardiography","volume":"33","author":"Pellikka","year":"2020","journal-title":"J. Am. Soc. Echocardiogr."},{"issue":"7","key":"10.1016\/j.ijcard.2023.131611_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/HCI.0000000000000053","article-title":"State of the art: imaging for myocardial viability: a scientific statement from the American Heart Association","volume":"13","author":"Garcia","year":"2020","journal-title":"Circ. Cardiovasc. Imag."},{"issue":"10","key":"10.1016\/j.ijcard.2023.131611_bb0065","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1093\/ehjci\/jev200","article-title":"Detection of viable myocardium and scar tissue","volume":"16","author":"Bax","year":"2015","journal-title":"Eur. Heart J. Cardiovasc. Imaging"},{"issue":"11","key":"10.1016\/j.ijcard.2023.131611_bb0070","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1001\/jama.2019.12843","article-title":"Effect of Sacubitril-valsartan vs Enalapril on aortic stiffness in patients with heart failure and reduced ejection fraction: a randomized clinical trial","volume":"322","author":"Desai","year":"2019","journal-title":"JAMA."},{"issue":"11","key":"10.1016\/j.ijcard.2023.131611_bb0075","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/CIRCULATIONAHA.118.037077","article-title":"Angiotensin receptor Neprilysin inhibitor for functional mitral regurgitation","volume":"139","author":"Kang","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.ijcard.2023.131611_bb0080","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ijcard.2022.01.004","article-title":"Benefit from sacubitril\/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: an echocardiographic study","volume":"350","author":"Carluccio","year":"2022","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcard.2023.131611_bb0085","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1002\/ehf2.13779","article-title":"Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril\/valsartan","volume":"9","author":"Dini","year":"2022","journal-title":"ESC Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2023.131611_bb0090","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/ehf2.14155","article-title":"Deformation imaging by strain in chronic heart failure over Sacubitril-valsartan: a multicenter echocardiographic registry","volume":"10","author":"Mandoli","year":"2023","journal-title":"ESC Heart Fail."},{"issue":"9507","key":"10.1016\/j.ijcard.2023.131611_bb0095","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(06)68074-4","article-title":"Controversies in ventricular remodelling","volume":"367","author":"Opie","year":"2006","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.ijcard.2023.131611_bb0100","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacc.2018.11.042","article-title":"Effects of Sacubitril\/valsartan on biomarkers of extracellular matrix regulation in patients with HFrEF","volume":"73","author":"Zile","year":"2019","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"10.1016\/j.ijcard.2023.131611_bb0105","doi-asserted-by":"crossref","first-page":"236","DOI":"10.4070\/kcj.2009.39.6.236","article-title":"Left ventricular Dyssynchrony after acute myocardial infarction is a powerful Indicator of left ventricular remodeling","volume":"39","author":"Ko","year":"2009","journal-title":"Korean Circ J."},{"key":"10.1016\/j.ijcard.2023.131611_bb0110","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.amjcard.2020.12.037","article-title":"Comparison of the efficacy and safety of Sacubitril\/valsartan versus Ramipril in patients with ST-segment elevation myocardial infarction","volume":"143","author":"Rezq","year":"2021","journal-title":"Am. J. Cardiol."},{"issue":"10","key":"10.1016\/j.ijcard.2023.131611_bb0115","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jchf.2020.05.005","article-title":"Sacubitril\/valsartan in advanced heart failure with reduced ejection fraction: rationale and design of the LIFE trial","volume":"8","author":"Mann","year":"2020","journal-title":"JACC Heart Fail."},{"issue":"6","key":"10.1016\/j.ijcard.2023.131611_bb0120","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jacc.2018.05.042","article-title":"Dynamic trajectories of left ventricular ejection fraction in heart failure","volume":"72","author":"Lup\u00f3n","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2023.131611_bb0125","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9040906","article-title":"Sacubitril\/valsartan induces global cardiac reverse remodeling in long-lasting heart failure with reduced ejection fraction: standard and advanced echocardiographic evidences","volume":"9","author":"Castrichini","year":"2020","journal-title":"J. Clin. Med."},{"issue":"9","key":"10.1016\/j.ijcard.2023.131611_bb0130","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2459\/JCM.0000000000001000","article-title":"Do the remodeling effects of sacubitril\/valsartan treatment depend upon heart failure duration?","volume":"21","author":"Villani","year":"2020","journal-title":"J. Cardiovasc. Med. (Hagerstown)"},{"issue":"13","key":"10.1016\/j.ijcard.2023.131611_bb0135","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMe1609826","article-title":"The ICD in heart failure - time for a rethink?","volume":"375","author":"McMurray","year":"2016","journal-title":"N. Engl. J. Med."},{"issue":"21","key":"10.1016\/j.ijcard.2023.131611_bb0140","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1161\/01.CIR.98.21.2334","article-title":"Sudden cardiac death","volume":"98","author":"Zipes","year":"1998","journal-title":"Circulation."},{"issue":"30","key":"10.1016\/j.ijcard.2023.131611_bb0145","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1093\/eurheartj\/ehv186","article-title":"Effect of the angiotensin-receptor-neprilysin inhibitor LCZ696 compared with enalapril on mode of death in heart failure patients","volume":"36","author":"Desai","year":"2015","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2023.131611_bb0150","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeab046","article-title":"Sacubitril\/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register","volume":"2","author":"Pastore","year":"2022","journal-title":"Eur Heart J Open."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323017011?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527323017011?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T21:04:20Z","timestamp":1759093460000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527323017011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":30,"alternative-id":["S0167527323017011"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131611","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Irreversible myocardial injury attenuates the benefits of sacubitril\/valsartan in heart failure patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2023.131611","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"131611"}}